黑龙江珍宝岛药业股份有限公司2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 证券代码：603567 证券简称：珍宝岛 黑龙江珍宝岛药业股份有限公司 2025 年第一季度报告 | 项目 | 本报告期 | 上年同期 | 本报告期比上年同 | | --- | --- | --- | --- | | | | | 期增减变动幅度(%) | | 营业收入 | 468,943,569.26 | 1,117,297,002.98 | -58.03 | | 归属于上市公司股东的净 | 75,295,443.26 | 293,365,824.9 ...

Financial Performance - The company's operating revenue for 2024 was approximately ¥1.43 billion, a decrease of 49.86% compared to ¥2.85 billion in 2023[22]. - The net profit attributable to shareholders for 2024 was a loss of approximately ¥17.30 million, an improvement of 96.52% from a loss of ¥497.57 million in 2023[22]. - The net cash flow from operating activities for 2024 was a negative ¥785.60 million, a decline of 476.2% compared to a positive cash flow of ¥208.83 million in 2023[22]. - The total assets at the end of 2024 were approximately ¥1.92 billion, down 50.94% from ¥3.91 billion at the end of 2023[22]. - The net assets attributable to shareholders at the end of 2024 were approximately -¥404.21 million, a decrease of 4.47% from -¥386.92 million at the end of 2023[22]. - The basic earnings per share for 2024 was -¥0.0393, an improvement of 96.52% from -¥1.1308 in 2023[22]. - The company reported a significant decline in its main business revenue, with the main business income for 2024 at approximately ¥1.22 billion, down from ¥2.52 billion in 2023[22]. - The company achieved total revenue of CNY 1.43 billion, a decrease of 49.86% compared to the previous year[31]. - The net profit attributable to shareholders was CNY -0.17 billion, with total assets of CNY 1.92 billion and net assets of CNY -0.40 billion[43]. - The gross margin for the main business was 23.92%, down from the previous year, with a 55.04% decrease in operating costs[47]. Operational Changes - The company closed 45 stores and transferred 15 stores during the reporting period, with only 1 new store opened[32][36]. - The company operates 32 stores, all of which are direct-operated, with a total leased area of 338,519.32 square meters[34]. - The company closed several stores, leading to a 32.16% reduction in selling expenses to ¥681,710,347.55 in 2024 from ¥1,004,823,368.19 in 2023[56]. - The company plans to focus on stabilizing its core business in the Northwest and South China regions to enhance operational efficiency[76]. - The company plans to sell certain subsidiaries to improve liquidity and operational efficiency, with specific sales scheduled for 2024[70]. Cash Flow and Investments - Cash flow from operating activities was CNY -785.60 million, a decline of 476.20% compared to CNY 208.83 million in the previous year[44]. - Investment activities generated a cash inflow of CNY 818.04 million, a significant increase of 486.22% from CNY 139.54 million[44]. - The total investment during the reporting period was 17,568,971.77, a significant decrease of 89.64% compared to the previous year[66]. - The company has engaged in the transfer of multiple subsidiaries, with significant financial impacts, including a transfer worth CNY 256.84 million[72]. Governance and Management - The company held 3 shareholder meetings during the reporting period, ensuring compliance with legal regulations and company bylaws[82]. - The board of directors consists of 9 members, including 3 independent directors, with a total of 8 board meetings and 7 committee meetings held during the reporting period[82]. - The company has experienced changes in its senior management, with multiple resignations impacting the board's composition and governance[89][90]. - The company is in the process of selecting new independent directors to maintain compliance with governance standards following recent resignations[89]. - The company has a robust governance structure, including a strategic committee, audit committee, nomination committee, and compensation and assessment committee[82]. Internal Control and Compliance - The company has received a negative opinion on its internal control report, indicating significant internal control deficiencies[4]. - The internal control audit report indicated that the company failed to maintain effective financial reporting internal controls as of December 31, 2024[127]. - The company has established a risk-oriented internal control system to adapt to changing external environments and internal management requirements[123]. - The company has faced issues with the management of seals and payment approvals, resulting in a lack of proper documentation and oversight[128]. - The company will disclose risks related to potential delisting in its annual report, emphasizing the importance of protecting shareholder interests[75]. Legal and Regulatory Matters - The company is involved in a contract dispute with Dongguan Yigousi Trading Co., with a claim amount of 5,329,100 CNY, which is not expected to form a liability[149]. - The company has a pending case with Shenzhen Xingyu Times Commercial Real Estate Investment Co., with a claim amount of 5,427,100 CNY, which is expected to form a liability[150]. - The company has multiple ongoing lawsuits related to supplier payment disputes, leading to the freezing of major bank accounts[151]. - The company is actively communicating with suppliers to resolve payment issues and is taking measures to address the situation[151]. Shareholder and Equity Matters - The total number of shares after the recent changes is 440,000,000, with 0% of limited shares remaining[179]. - The company has seen a reduction of 66,825,000 limited shares, which previously accounted for 15.19% of total shares[179]. - The largest shareholder, Xi'an Tongji Yongle Commercial Operation Management Co., holds 172,904,100 shares, accounting for 39.30% of total shares[184]. - The total number of shares frozen for the largest shareholders amounts to 265,942,966 shares, which is 100% of their holdings[184]. - The company has not engaged in any repurchase transactions among the top 10 shareholders during the reporting period[185].

Financial Performance - The company's operating revenue for the third quarter was ¥262,156,808.27, a decrease of 11.91% compared to the same period last year[4] - Net profit attributable to shareholders was ¥28,609,951.22, down 52.59% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥18,988,078.64, reflecting a decline of 65.47% compared to the previous year[4] - In the first three quarters of 2024, the company achieved operating revenue of CNY 880 million, a decrease of 12.10% year-on-year[15] - The net profit attributable to shareholders was CNY 175 million, down 23.42% compared to the same period last year[15] - Total operating revenue for the first three quarters of 2024 was ¥879,824,587.76, a decrease of 12.1% compared to ¥1,000,961,989.28 in the same period of 2023[23] - Net profit for the first three quarters of 2024 was ¥181,904,536.85, a decline of 22.2% from ¥233,662,791.59 in the previous year[24] - Total comprehensive income for the period was CNY 189,620,691.30, a decrease from CNY 234,143,463.91 in the previous year[25] Earnings and Shareholder Returns - Basic and diluted earnings per share were both ¥0.06, a decrease of 50.00% compared to the same period last year[4] - Basic and diluted earnings per share decreased to CNY 0.35 from CNY 0.45 year-over-year[25] - The weighted average return on equity decreased to 1.10%, down 1.32 percentage points year-on-year[4] Cash Flow and Liquidity - Cash flow from operating activities for the year-to-date was ¥249,907,045.22, an increase of 70.58%[4] - The cash and cash equivalents as of September 30, 2024, were CNY 536.59 million, up from CNY 484.33 million at the end of 2023[18] - The company's cash and cash equivalents decreased to ¥1,930,829,694.44 from ¥2,151,184,140.66 year-over-year[20] - Net cash flow from operating activities increased to CNY 249,907,045.22, compared to CNY 146,507,664.68 in the same period last year, representing a growth of 70.5%[28] - Cash inflow from operating activities totaled CNY 1,125,151,015.42, down from CNY 1,268,627,997.86, a decline of 11.3%[27] - Cash outflow from operating activities decreased to CNY 875,243,970.20 from CNY 1,122,120,333.18, a reduction of 22.0%[28] - Net cash flow from investing activities was negative at CNY -139,612,486.27, an improvement from CNY -349,098,239.79 in the previous year[28] - Cash flow from financing activities resulted in a net outflow of CNY -53,954,549.19, compared to CNY -38,940,372.59 last year[28] - The ending cash and cash equivalents balance increased to CNY 536,086,628.64 from CNY 407,471,086.12 year-over-year[29] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,839,310,398.65, an increase of 4.40% from the end of the previous year[5] - Total liabilities increased to ¥1,161,681,548.46, compared to ¥1,030,379,608.82 in the previous year[20] - The total owner's equity decreased slightly to ¥2,677,628,850.19 from ¥2,741,246,444.12 year-over-year[21] - The company reported a significant increase in long-term equity investments, rising to ¥122,870,201.52 from ¥50,873,981.61[20] Operational Highlights - The core product, Getein1600, had over 400 units installed in the first three quarters of 2024[15] - The sales revenue from the chemical luminescence line reached CNY 196 million, an increase of 38.43% year-on-year[15] - The overseas revenue from conventional products was CNY 84.99 million, a year-on-year increase of 20.31%[16] - The company installed over 710 units of the small luminescence product MAGICL6000 and MAGICL6000i in various hospitals[15] - The company has installed over 70 units of the Metis6000 fully automated biochemical immunoassay line since its launch[15] Non-Recurring Items - The company recognized government subsidies amounting to ¥6,537,901.80 during the reporting period, contributing positively to the financial results[8] - Non-recurring gains and losses totaled ¥9,621,913.14 for the current period, with a significant portion attributed to government subsidies and other income[9] Changes in Consolidation - The company has decided to no longer consolidate Wuhan Jingchuan Diagnostic Technology Co., Ltd. into its financial statements starting July 1, 2024[16]

Financial Performance - The net profit attributable to shareholders for the fiscal year 2024 was RMB -329,284,992.23, with an ending undistributed profit of RMB 29,693,059.21[6] - The net profit for the parent company for the fiscal year 2024 was RMB 61,252,605.60, with an ending undistributed profit of RMB 61,275,264.15[6] - The company's operating revenue for 2024 was CNY 2,052,481,004.27, a decrease of 34.01% compared to CNY 3,110,391,899.46 in 2023[26] - The net profit attributable to shareholders for 2024 was a loss of CNY 329,284,992.23, a decline of 647.21% from a profit of CNY 60,175,637.74 in 2023[26] - The basic earnings per share for 2024 was -CNY 0.77, down 650.00% from CNY 0.14 in 2023[27] - The net cash flow from operating activities decreased by 195.74% to -CNY 419,004,217.45 in 2024, compared to CNY 437,631,546.39 in 2023[28] - The company's total assets at the end of 2024 were CNY 6,341,138,711.37, a decrease of 1.00% from CNY 6,405,157,470.02 at the end of 2023[26] - The weighted average return on equity for 2024 was -21.40%, a decline of 24.86% from 3.46% in 2023[27] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -CNY 357,617,902.36, a decrease of 3,575.13% from CNY 10,290,789.13 in 2023[26] Business Strategy and Development - The company plans not to distribute profits or increase capital reserves for the fiscal year 2024, focusing on sustainable development[6] - The company aims to enhance market competitiveness and optimize internal management under the "14th Five-Year Plan" strategy[37] - The company is committed to long-term sustainable development and strategic planning, with a focus on industry consolidation and quality growth[44] - The company is reducing its reliance on new real estate construction by focusing on the renovation and repainting market, which is expected to grow significantly[39] - The company is actively exploring international business opportunities, having already exported products to Southeast Asia and Central Asia, and is working on technology exports to developed countries[71] - The company is focused on enhancing its operational efficiency and management effectiveness through the application of AI technologies and knowledge bases by 2025[53] - The company aims to provide customized coating solutions for nearly 600 million rural users, supporting the national beautiful countryside initiative[65] Product and Market Innovation - The company has established a comprehensive product and service system for B-end business, focusing on integrated solutions in the construction coating sector[37] - The company has introduced the "Creative Gold Board" CMCP, a fireproof aluminum composite decorative material, to meet the demand for high-end residential exterior decoration[37] - The company has launched a new fireproof insulation board, which utilizes a unique copolymer modification technology to enhance fire resistance while maintaining high insulation performance, validated by multiple international fire tests[92] - The company has developed a diverse product line across six major industries, including coatings, finished boards, insulation, waterproofing, mortar, and new home materials[72] - The company has developed approximately 83 series and 639 categories of functional architectural coatings, including products with high decorative, color retention, stain resistance, weather resistance, and crack resistance characteristics[141] - The company has completed the development of 24 new products, including high-performance coatings and environmentally friendly materials[192] Operational Efficiency and Supply Chain - The company has established an efficient supply chain consisting of 1 headquarters in Shanghai, 5 comprehensive smart manufacturing bases, and 20 specialized factories, forming a "1+5+20" model to reduce overall costs[48] - The company has a localized supply capability of 150-300 kilometers, enhancing its cost leadership advantage[153] - The company employs a production model based on customer orders, utilizing both self-production and commissioned production to optimize efficiency[187] - The company has formed a strategic partnership with Alibaba Cloud for digital transformation, enhancing management efficiency and supply chain operations[154] Research and Development - Research and development expenses amounted to 70.44 million yuan, a decrease of 25.56% year-on-year, indicating a strategic focus on cost management[152] - The company holds 238 valid patents, including 140 invention patents, reflecting its strong emphasis on intellectual property and innovation[152] - The company has established partnerships with academic institutions for research and development, enhancing its technological capabilities[152] - The company is currently in the small-scale testing phase for weather-resistant water-based asphalt waterproof coatings[192] - The company has made significant advancements in the research of graphene modification for high-performance coatings[192] Market Trends and Challenges - The overall industry is facing a downward cycle due to weakened downstream demand and high raw material prices, leading to intensified competition[139] - The Chinese architectural coatings market is currently estimated to be between ¥175 billion and ¥200 billion, with a total output of 26.398 million tons and a main business revenue of ¥298.27 billion in the first three quarters of 2024, showing a year-on-year growth of 0.6%[183] - The insulation and decorative board market is expected to exceed 230 million square meters by 2025, driven by energy-saving standards and the integration of prefabricated buildings[184] - The waterproof materials market is currently valued at around ¥200 billion, with increasing market concentration and competitiveness among large enterprises[186] Customer Engagement and Satisfaction - Customer satisfaction ratings improved by 15%, indicating a positive reception of recent product innovations[198] - The company aims to integrate its marketing strategies across various sectors, including public infrastructure and housing projects, to create a comprehensive marketing network[151]

Financial Performance - The company's operating revenue for 2024 was approximately ¥1.36 billion, a decrease of 17.66% compared to ¥1.65 billion in 2023[22]. - Net profit attributable to shareholders for 2024 was approximately ¥63.85 million, down 50.06% from ¥127.86 million in 2023[22]. - The net profit after deducting non-recurring gains and losses was approximately ¥41.27 million, a decline of 61.42% compared to ¥106.96 million in 2023[22]. - The net cash flow from operating activities for 2024 was approximately ¥165.98 million, a decrease of 63.79% from ¥458.41 million in 2023[22]. - The total assets at the end of 2024 were approximately ¥3.16 billion, down 5.44% from ¥3.34 billion at the end of 2023[22]. - The net assets attributable to shareholders at the end of 2024 were approximately ¥2.65 billion, a decrease of 3.86% from ¥2.75 billion at the end of 2023[22]. - Basic earnings per share for 2024 were ¥0.27, a decrease of 50.00% compared to ¥0.54 in 2023[23]. - The weighted average return on net assets for 2024 was 2.35%, a decrease of 2.24 percentage points from 4.59% in 2023[23]. Market and Product Development - The company launched the GVT (Gear, Variable, Transmission) technology platform and introduced the G500A automatic five-speed hub, enhancing the riding experience and expanding its product line[33]. - The company filed 37 patent applications and received 35 authorizations in 2024, indicating a strong focus on R&D and innovation[33]. - The company aims to improve customer satisfaction by upgrading service mechanisms and establishing a 24-hour response system, emphasizing quality as a core competitive advantage[34]. - The European e-bike market is expected to recover post-2025, with the industry projected to maintain an upward trend until 2030, despite current challenges[35]. - The U.S. market for e-bikes is anticipated to grow significantly, with an estimated import of 1.7 million electric bicycles in 2024, highlighting the market's potential[36]. - By the end of 2024, China's electric bicycle ownership is projected to reach 400 million units, reflecting strong domestic demand[37]. Operational Efficiency - The company reported a significant increase in cash flow from operating activities in Q2 2024, amounting to approximately ¥49.24 million[25]. - The company’s net profit attributable to shareholders decreased to ¥0.60 million in Q3 2024, indicating challenges in maintaining profitability during that period[25]. - The company is committed to enhancing product performance and quality control as part of its strategic focus for 2025[34]. - The main business revenue from electric bicycle motors was 591.63 million RMB, a decrease of 20.38% compared to the previous year, with a gross margin of 41.30%[55]. - The revenue from battery sales was 135.00 million RMB, with a gross margin of 13.05%, reflecting a decrease of 6.73% in cost[55]. - The company employs a "make-to-order" production model, responding flexibly to customer specifications and order timelines[44]. Research and Development - The company has a strong R&D capability, being one of the few globally to master core technology in torque sensors, with products meeting international advanced standards[42]. - The company plans to continue increasing R&D investment to develop better-performing products based on existing offerings[46]. - Research and development expenses totaled ¥82,186,112.79, representing 6.06% of operating revenue, a decrease of 8.55% from ¥89,868,605.33 in the previous year[63]. Risk Management - The company has outlined potential risks in its report, advising investors to be cautious regarding future plans and strategies[8]. - The company faces risks from changes in international trade environments, particularly in Europe and North America, which could impact its competitive position[84]. - The company is exposed to market competition risks, especially in the electric bicycle system sector, where it competes with established brands like Bosch and Shimano[85]. - The company is at risk of technological obsolescence if its R&D does not align with industry trends and market demands[85]. - The company is vulnerable to fluctuations in raw material prices, such as neodymium and aluminum, which could increase operational costs[85]. Corporate Governance - The board of directors approved the 2023 annual report and financial statements, including profit distribution and capital reserve transfer plans[93]. - The total number of shares held by Chairman Wang Qinghua increased from 68,040,000 to 95,256,000, reflecting a change of 27,216,000 shares due to capital reserve transfer[97]. - Vice Chairman Yu Zhenhua's shareholding rose from 14,536,200 to 20,350,680, with an increase of 5,814,480 shares attributed to capital reserve transfer[97]. - The company has committed to avoiding competition with its controlling shareholders and related entities[93]. - The company has established a salary policy that links compensation to economic performance and aims to maintain competitive salary levels in the industry[119]. Environmental Responsibility - The company invested 40.42 million yuan in environmental protection during the reporting period[137]. - The company has established mechanisms for environmental protection and complies with all relevant regulations regarding waste discharge[138]. - The company reported zero production wastewater, with only domestic sewage treated and discharged into the municipal system[144]. - The company achieved compliance with air pollution discharge standards, including welding and cooking emissions[138]. - The company has implemented a comprehensive waste management strategy, achieving zero solid waste discharge[144]. Shareholder Returns - The company achieved a net profit attributable to ordinary shareholders of RMB 63,845,821.74, with a cash dividend amount of RMB 23,461,797.90, representing 36.75% of the net profit[129]. - The company plans to distribute cash dividends of no less than 20% of the distributable profit each year, with a cumulative cash dividend over the last three years amounting to RMB 430,850,290.90, which is 183.64% of the average annual net profit[131]. - The company has established a cash dividend policy that prioritizes cash distributions, ensuring that at least 20% of the distributable profit is allocated to cash dividends annually[124]. Employee Development - The company conducted over 128 internal and external training sessions, covering 1,967 employee instances, focusing on technical and quality aspects[121]. - The company has recognized 134 individuals in four occupational categories for vocational skills, with 126 obtaining certification and 61 being trained as skilled workers[120]. - The company has a robust training management process, enhancing employee professional skills and career development opportunities[121]. Financial Management - The company has engaged in cash asset management, with a total of RMB 317,360,220 in bank wealth management products and an outstanding balance of RMB 89,858,860[178]. - The company has completed three USD fixed deposits totaling USD 10 million, with interest income of approximately USD 234,200[179]. - The company reported a total of 8,000 million in structured financial products with a guaranteed return of 1.05%[182]. - The company has a projected return of 1.50% on 5,000 million in structured financial products, with a decrease of 25.6% in performance metrics[182].

Financial Performance - The company's operating revenue for Q1 2025 was ¥54,241,274.96, a decrease of 25.86% compared to ¥73,156,159.83 in the same period last year[5]. - The net profit attributable to shareholders was -¥15,125,989.59, representing a decline of 287.73% from a profit of ¥8,057,481.58 in the previous year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥16,800,503.91, a decrease of 555.82% compared to ¥3,685,783.64 in the same period last year[5]. - The basic earnings per share were -¥0.05, down 266.67% from ¥0.03 in the previous year[5]. - The diluted earnings per share were also -¥0.05, reflecting a 266.67% decrease from ¥0.03 in the same period last year[5]. - The total comprehensive income attributable to the parent company was -15,125,989.59 RMB, compared to 8,057,481.58 RMB in the previous year[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,509,986,780.03, down 5.86% from ¥1,604,030,568.64 at the end of the previous year[6]. - The equity attributable to shareholders was ¥966,161,035.57, a decrease of 1.51% from ¥980,970,540.40 at the end of the previous year[6]. - Total liabilities decreased to CNY 424,589,981.04 as of March 31, 2025, from CNY 495,080,870.37 as of December 31, 2024, a reduction of 14.3%[15]. - The company reported a decrease in accounts receivable to CNY 211,694,262.69 as of March 31, 2025, from CNY 243,932,956.28 as of December 31, 2024, a decline of 13.2%[13]. Cash Flow - The net cash flow from operating activities was -¥49,746,084.10, compared to -¥44,949,892.57 in the same period last year[5]. - Cash inflows from operating activities amounted to 77,815,976.32 RMB, an increase from 52,317,227.87 RMB year-over-year[22]. - Cash outflows from operating activities totaled 127,562,060.42 RMB, compared to 97,267,120.44 RMB in the previous year[23]. - The net cash flow from investing activities was -8,550,438.24 RMB, a decline from a positive 29,100,681.84 RMB in the same period last year[23]. - Cash inflows from financing activities were 34,900,000.00 RMB, compared to 16,046,575.29 RMB in the previous year[24]. - The net cash flow from financing activities was -30,743,323.55 RMB, compared to a positive 16,035,023.53 RMB in the previous year[24]. - The ending cash and cash equivalents balance was 69,001,428.88 RMB, down from 74,861,111.35 RMB at the end of the previous year[24]. Operating Costs and Expenses - Total operating costs increased to CNY 83,899,864.35 in Q1 2025, up from CNY 70,123,357.99 in Q1 2024, representing a 19.6% increase[18]. - Research and development expenses for Q1 2025 were CNY 7,235,352.40, compared to CNY 3,531,589.25 in Q1 2024, an increase of 104.8%[19]. - Cash and cash equivalents decreased to CNY 69,962,467.62 as of March 31, 2025, from CNY 160,390,031.32 as of December 31, 2024, a decline of 56.4%[13]. Profitability - Net profit for Q1 2025 was a loss of CNY 23,869,384.04, compared to a profit of CNY 8,057,481.58 in Q1 2024[19]. - Operating profit for Q1 2025 was a loss of CNY 26,468,461.02, down from a profit of CNY 9,361,039.41 in Q1 2024[19].

Financial Performance - The company's operating revenue for 2024 was CNY 1,164,798,937.40, a decrease of 14.93% compared to CNY 1,369,162,256.52 in 2023[22]. - Net profit attributable to shareholders for 2024 was CNY 223,636,488.43, down 20.06% from CNY 279,771,914.08 in 2023[22]. - The basic earnings per share for 2024 was CNY 0.44, reflecting a decline of 20.00% from CNY 0.55 in 2023[23]. - The cash flow from operating activities increased by 26.94% to CNY 422,998,055.82 in 2024, compared to CNY 333,220,661.81 in 2023[24]. - The company's total assets at the end of 2024 were CNY 3,707,374,587.49, a decrease of 1.70% from CNY 3,771,626,052.94 at the end of 2023[22]. - The weighted average return on equity for 2024 was 8.64%, down from 11.17% in 2023, a decrease of 2.53 percentage points[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 202,042,109.65, a decrease of 16.33% from CNY 241,487,200.13 in 2023[22]. - The company reported a loss of CNY 8,087,939.59 from the disposal of non-current assets in 2024[29]. - The total cash dividends distributed during the reporting period amounted to RMB 91,287,633.06, representing 40.82% of the net profit attributable to shareholders of the listed company[6]. - The company achieved total revenue of CNY 1,164,798,937.40, a year-on-year decrease of 14.93%[79]. - The company's net profit attributable to shareholders was CNY 22,363.65 million, down 20.06% year-on-year[79]. Research and Development - The company invested 207 million RMB in R&D in 2024, focusing on chemiluminescence instruments, line systems, and core raw materials, resulting in 373 new patent authorizations[41]. - The company is focusing on R&D investments in molecular diagnostic systems and smart laboratories, integrating AI-assisted diagnostic technology with hardware[72]. - The company plans to continue increasing investment in R&D projects to enhance product performance and reduce production costs[43]. - The company has 497 R&D personnel, accounting for 25.53% of the total workforce[96]. - The company emphasizes continuous R&D innovation as a core driver, enhancing comprehensive innovation capabilities to expand terminal coverage in the clinical diagnostic market[70]. Product Development and Innovation - The company launched the fully automated biochemical analyzer CM800 with a throughput of 800 tests per hour, featuring 137 sample positions and 114 reagent positions[60]. - The Metis6000 fully automated biochemical immunoassay line was installed nearly 90 times in 2024, with a total of about 140 installations since its launch, 70% of which were in secondary and lower-level hospitals[36]. - The company has established eight major technology platforms, including POCT, chemiluminescence, biochemical testing, and molecular testing, expanding from low-throughput to high-throughput automated systems[57]. - The company has transitioned from a single POCT product line to a diverse product range, including chemiluminescence and biochemical products, and is expanding into both tiered hospitals and overseas markets[57]. - The company launched the GN7120 fully automatic nucleic acid amplification analyzer, enhancing its product matrix for small and medium hospitals[74]. Market Presence and Expansion - The company has expanded its overseas market presence to cover 130 countries and regions, establishing good cooperation with local distributors and healthcare institutions[64]. - The company plans to expand its overseas market presence, particularly promoting its small luminescence products MAGICL6000 and MAGICL6000i across Europe, Africa, Asia, and Latin America[116]. - The company has established over 2,000 product import licenses in 66 countries as of December 31, 2024, enhancing its international market presence[45]. - The overseas revenue from conventional products reached 137 million RMB, representing a year-on-year growth of 4.53%[44]. - The company has installed nearly 40 units of the CM-400 and approximately 70 units of the MAGICL6000 and MAGICL6000i in overseas markets, indicating strong growth potential[45]. Governance and Compliance - The company has established an independent financial department with a complete accounting system, ensuring financial independence[129]. - The company maintains independent operations with no shared bank accounts with controlling shareholders[130]. - The company has a complete and independent asset structure, with no instances of fund or asset occupation by controlling shareholders[128]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal and regulatory requirements[127]. - The company has implemented internal control systems to ensure effective management of subsidiaries and mitigate operational risks[167]. Environmental and Social Responsibility - The company invested 512,300 RMB in environmental protection during the reporting period[172]. - The company ensures that wastewater meets the required standards before being discharged, with regular monitoring of water quality parameters[174]. - The company has implemented measures to control noise pollution, ensuring compliance with relevant noise emission standards[176]. - The company has established a hazardous waste storage facility that meets regulatory requirements and has signed agreements with qualified disposal companies for waste management[176]. - Total donations amounted to 724,000 CNY, with 668,200 CNY in cash contributions[179]. Shareholder Relations and Dividends - The company has committed to a three-year shareholder return plan for 2023-2025, which was approved in the extraordinary shareholder meeting[131]. - The total cash dividend amount for the current period is CNY 91,287,633.06, which represents 40.82% of the net profit attributable to ordinary shareholders[163]. - The company plans to distribute dividends in cash, stock, or a combination of both, with a minimum cash distribution of 10% of the distributable profit for the year if there are no major investment plans or cash expenditures[157]. - The cash dividend distribution ratio is set at a minimum of 80% for mature companies without major expenditures, 40% for mature companies with major expenditures, and 20% for growth-stage companies with major expenditures[158]. - Over the last three accounting years, the cumulative cash dividend amount is CNY 344,864,391.56, with an average annual net profit of CNY 334,106,127.64, resulting in a cash dividend ratio of 103.22%[165].

Financial Performance - The company's operating revenue for 2024 was RMB 469,138,106.22, a decrease of 6.80% compared to RMB 503,365,193.98 in 2023[21] - The net profit attributable to shareholders of the listed company was RMB 9,963,885.90, down 87.80% from RMB 81,657,794.39 in the previous year[22] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB -16,428,297.80, a decline of 129.33% compared to RMB 56,017,525.59 in 2023[22] - The net cash flow from operating activities was RMB 24,815,534.82, a decrease of 70.25% from RMB 83,408,976.98 in the previous year[22] - Basic earnings per share decreased by 89.29% to CNY 0.03 in 2024 from CNY 0.28 in 2023[23] - Diluted earnings per share also fell by 89.29% to CNY 0.03 in 2024 compared to CNY 0.28 in 2023[23] - The weighted average return on equity dropped by 7.21 percentage points to 0.99% in 2024 from 8.20% in 2023[23] - The net profit attributable to shareholders for Q1 2024 was CNY 8,057,481.58, while Q2 and Q3 reported losses of CNY 3,471,685.61 and CNY 18,241,531.71 respectively[26] Revenue Breakdown - Total operating revenue for 2024 was CNY 232,402,909.48, with Q3 contributing CNY 90,111,793.23[26] - The elevator industry accounts for over 69.42% of the company's revenue, indicating a strong focus on this sector amidst increasing competition and market consolidation[46] - The military simulation industry contributed ¥138,939,646.76 in revenue, with a gross margin of 54.12%[66] - The company's revenue from the elevator control system products was CNY 330.46 million, while the military simulation system products contributed CNY 138.94 million to the total revenue[71] Asset Management - Total assets increased by 31.44% to RMB 1,604,030,568.64 from RMB 1,220,369,867.13 in 2023[22] - The net assets attributable to shareholders of the listed company decreased by 4.71% to RMB 980,970,540.40 from RMB 1,029,509,947.80 in 2023[22] - The company's trading financial assets increased to 257.78 million RMB, with a fair value change of 11.61 million RMB during the reporting period[81] - The total current assets increased to RMB 947.89 million as of December 31, 2024, compared to RMB 814.04 million as of December 31, 2023, reflecting a growth of approximately 16.4%[200] Investment and Acquisitions - The company completed the acquisition of Beijing Lingwei Military Simulation Technology Co., Ltd. in August 2024, which is now a subsidiary included in the consolidated financial statements[52] - The company acquired a 30.79% stake in Lingwei Junrong, increasing its voting rights to 69.83% after the completion of the acquisition[70] - The company acquired a 41.96% stake in Beijing Lingwei Military Technology Co., Ltd. for approximately 350.83 million RMB, completing the acquisition on August 10, 2024[80] - The company has signed a performance commitment and compensation agreement with the existing shareholders of Lingwei Junrong, which includes specific profit targets for the upcoming years[145] Research and Development - The company’s R&D expenses increased by 5.24% to ¥19,774,527.60[65] - The total R&D expenditure was CNY 19.77 million, accounting for 4.22% of the operating revenue[73] - The company filed 16 utility model patents and 1 invention patent in 2024, with 4 invention patents and 8 utility model patents granted[50] - The company has a strong talent pool in various fields, including frequency control and artificial intelligence, supporting its innovation capabilities[62] Risk Management - The company faces risks from macroeconomic fluctuations affecting market demand, particularly linked to the real estate and urban infrastructure sectors[92] - The company is addressing the risk of intensified market competition by increasing R&D investment and maintaining product and service quality[93] - The company is managing the risk of raw material price fluctuations by improving production processes and cost management[94] - The company is cautious about accounts receivable risks, actively controlling credit limits and selecting partners to mitigate potential bad debt[94] Governance and Compliance - The company has established a governance structure that ensures clear responsibilities and effective checks and balances among the board, supervisory committee, and management[100] - There are no significant differences between the company's governance practices and the regulations set by the China Securities Regulatory Commission[100] - The company has not reported any related party transactions that would impact its governance structure[101] - The company has established a comprehensive internal control system to ensure compliance and accurate financial reporting[131] Future Outlook - The company has committed to achieving a net profit of RMB 4,100 million, RMB 7,000 million, RMB 8,300 million, and RMB 9,300 million for the years 2024 to 2027, totaling no less than RMB 28,700 million[145] - The company plans to invest in R&D for medical rehabilitation devices, leveraging military technology for civilian applications[88] - The company aims to enhance market share by deepening cooperation with existing clients and accelerating the development of new clients, targeting a significant increase in sales by 2025[89] - The company anticipates a shift in the elevator industry towards service-oriented models, driven by increasing maintenance service demand as elevator usage rises[85]

Financial Performance - The company expects a net profit attributable to shareholders of approximately 996.39 million yuan for 2024, a decrease of 87.80% compared to the previous year[6]. - The net profit after deducting non-recurring gains and losses is projected to be -1,642.83 million yuan, representing a decrease of 129.33% year-on-year[6]. - The estimated operating revenue for 2024 is 46,913.81 million yuan, with a revenue of 46,462.70 million yuan after excluding unrelated business income[6]. - In the previous year, the net profit attributable to shareholders was 8,165.78 million yuan, and the net profit after deducting non-recurring gains and losses was 5,601.75 million yuan[8]. Revenue Recognition and Impairment - The company plans to adjust revenue recognition for certain military projects due to insufficient acceptance confirmation, impacting the projected revenue and profit[10]. - A goodwill impairment of 518.68 million yuan has been recognized due to delays in the delivery and acceptance of military projects, affecting the overall profit forecast[10]. - The company has a substantial backlog of orders, but the performance of its subsidiary is not expected to meet the agreed standards due to project delays[10]. Financial Reporting and Investor Guidance - The financial data provided is preliminary and subject to change upon the release of the official annual report[12]. - The company has communicated with auditors and found no significant uncertainties affecting the accuracy of the revised profit forecast[11]. - Investors are advised to be cautious regarding investment risks based on the revised financial outlook[12].

Financial Performance - The company's operating revenue for Q1 2025 was ¥300,764,124.17, representing a 1.69% increase compared to ¥295,775,274.91 in the same period last year[3]. - Net profit attributable to shareholders increased by 32.11% to ¥21,844,670.32 from ¥16,535,627.48 year-on-year[3]. - Basic and diluted earnings per share rose by 28.57% to ¥0.09 from ¥0.07 in the same period last year[3]. - Operating profit for Q1 2025 was ¥26,133,424.56, up from ¥18,727,238.69 in Q1 2024, marking an increase of 39.5%[18]. - The total comprehensive income for the first quarter of 2025 was CNY 24,807,105.07, compared to CNY 15,160,824.41 in the first quarter of 2024, representing a significant increase[19]. - Net profit for Q1 2025 was ¥21,844,670.32, representing a 32.2% increase compared to ¥16,535,627.48 in Q1 2024[18]. Cash Flow - The net cash flow from operating activities surged to ¥21,218,315.91, a significant increase of 2,134.46% compared to ¥949,595.57 in the previous year[3]. - Cash flow from operating activities for Q1 2025 was CNY 21,218,315.91, a substantial increase from CNY 949,595.57 in Q1 2024[21]. - The company's cash outflows for operating activities in Q1 2025 were CNY 310,343,789.31, compared to CNY 321,801,199.97 in Q1 2024, showing a decrease of approximately 3.5%[21]. - The cash flow from operating activities showed a net outflow of CNY 31.07 million, an improvement from a net outflow of CNY 35.63 million in Q1 2024[28]. Assets and Liabilities - Total assets decreased by 2.33% to ¥3,085,844,240.68 from ¥3,159,602,486.24 at the end of the previous year[4]. - The company's total assets amounted to ¥3,085,844,240.68, down from ¥3,159,602,486.24 in the previous period[13]. - Total liabilities decreased to ¥415,548,988.92 from ¥514,114,339.55, a decline of 19.2%[14]. - The total liabilities as of March 31, 2025, were CNY 162,686,365.50, down from CNY 202,257,722.13 at the end of 2024[23]. Shareholder Equity - The equity attributable to shareholders increased by 0.94% to ¥2,670,295,251.76 compared to ¥2,645,488,146.69 at the end of the previous year[4]. - The company's equity attributable to shareholders increased to ¥2,670,295,251.76 from ¥2,645,488,146.69, a growth of 0.9%[14]. - The total equity of the company reached CNY 2.64 billion, up from CNY 2.60 billion year-over-year[24]. Expenses - The company reported a significant reduction in expenses and an increase in investment income as the main reasons for the profit growth[4]. - Research and development expenses decreased to ¥13,190,933.56 in Q1 2025 from ¥19,674,202.82 in Q1 2024, a reduction of 33.1%[18]. - Research and development expenses in Q1 2025 were CNY 10.95 million, down 30.7% from CNY 15.79 million in Q1 2024[25]. - The company experienced a decrease in sales expenses, which were CNY 7.82 million in Q1 2025, down 41.0% from CNY 13.30 million in Q1 2024[25]. Investment Activities - The company reported cash inflows from investment activities of CNY 774,877,354.49 in Q1 2025, compared to CNY 1,483,271.10 in Q1 2024[21]. - The net cash flow from investment activities for Q1 2025 was CNY 80,936,289.40, a turnaround from a negative cash flow of CNY -97,028,870.84 in Q1 2024[21]. - The company reported a significant increase in investment cash inflow, totaling CNY 774.43 million in Q1 2025 compared to CNY 576.59 million in the previous year[29]. Other Comprehensive Income - Other comprehensive income after tax for Q1 2025 was ¥2,962,434.75, compared to a loss of ¥1,374,803.07 in Q1 2024[18]. - The company's cash and cash equivalents at the end of Q1 2025 were CNY 752,180,251.89, compared to CNY 1,419,754,490.21 at the end of Q1 2024, indicating a decrease of approximately 47.1%[21].